DICOT

dicot-logo

Dicot is a pharmaceutical company focused on drug discovery and the development of novel lifestyle drugs to enrich patients' lives. The Company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in the pre-clinical stage of development.

#SimilarOrganizations #Website #More

DICOT

Social Links:

Industry:
Health Care Lifestyle Manufacturing Pharmaceutical

Founded:
2018-01-01

Address:
Uppsala, Uppsala Lan, Sweden

Country:
Sweden

Website Url:
http://www.dicot.se

Total Employee:
1+

Status:
Active

Contact:
+46 (0) 70-663 60 09

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag JsDelivr


Similar Organizations

arpida-ag-logo

Arpida AG

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.

tibotec-logo

Tibotec

Tibotec is a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV .

Official Site Inspections

http://www.dicot.se Semrush global rank: 10.36 M Semrush visits lastest month: 1

  • Host name: solnabergproperty.com
  • IP address: 81.170.239.161
  • Location: Stockholm Sweden
  • Latitude: 59.3307
  • Longitude: 18.0718
  • Timezone: Europe/Stockholm
  • Postal: 110 57

Loading ...

More informations about "Dicot"

Board - Dicot

She was previously chairman of Apotekarsocieteten and vice chairman of the trade organization SwedenBIO. Independent director. Chairman since 2021, board member since 2021. ...See details»

Board professional Eva Sjökvist Saers new chairman of Dicot

Feb 9, 2021 Thereafter, Dicot's intention is to form strategic alliances, or alternatively carry out a trade sale, with larger, established pharmaceutical companies to be able to introduce LIB-01 โ€ฆSee details»

Dicot - Crunchbase Company Profile & Funding

Organization. Dicot . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email โ€ฆSee details»

Dicot Pharma AB | LinkedIn

Dicot Pharma AB | 1 368 följare på LinkedIn. Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. | Dicot is a โ€ฆSee details»

Dicot Expands its Management Team - Dicot

December 12, 2019, Uppsala, Sweden - Dicot AB (publ) ("Dicot" or the "Company") today announced that the company has expanded its management team with the addition of Jessica โ€ฆSee details»

Dicot signs Agreement for Contract Research with Pelvipharm

November 6, 2019, Uppsala, Sweden - Dicot AB (publ) ("Dicot" or the "Company") announced today that the company has entered into a research collaboration agreement with Pelvipharm, โ€ฆSee details»

DICOT.SE | Dicot AB Company Profile & Executives - WSJ

Company profile for Dicot AB including key executives, insider trading, ownership, revenue and average growth rates. View detailed DICOT.SE description & address.See details»

DICOT | Dicot AB Profile - MarketWatch

Dicot AB company facts, information and financial ratios from MarketWatch.See details»

Dicot AB Company & People | DICOT - Barron's

Dicot AB company and executive profile by Barron's. View the latest DICOT company infomation and executive bios.See details»

MFN.se > Dicot > Dicot AB (publ): Board professional Eva Sjökvist โ€ฆ

In a couple of years, sales almost tripled and went from SEK 500 million to SEK 1.3 billion. During the years 2008-2016, Eva was the first ever female chairman of the board of The Pharmacy โ€ฆSee details»

Dicot Pharma AB - Cision News

Jun 6, 2024 Thereafter, Dicot's intention is to form strategic alliances, or alternatively carry out a trade sale, with larger, established pharmaceutical companies to be able to introduce LIB-01 โ€ฆSee details»

Dicot's study results presented today at European Society for

The European Society for Sexual Medicine (ESSM) is a leading scientific organization in sexual medicine. The annual congress is now underway, bringing together prominent researchers โ€ฆSee details»

Dicot AB (publ): Board professional Eva Sjökvist Saers new โ€ฆ

Press release: Uppsala, February 9, 2021. At an Extraordinary General Meeting on February 9, Dr Eva Sjökvist Saers was elected new Chairman of the Board of Dicot, which is developing a โ€ฆSee details»

Summary of Interim Report January - March 2021, Dicot AB - Dicot

A summary of the Interim report January - March 2021, for Dicot AB (publ) is now avalible on the company webbsite www.dicot.se . January - March 2021. Net sales amounts to KSEK 37 (0) โ€ฆSee details»

Today Dicot AB becomes Dicot Pharma AB | Placera

May 30, 2024 E-mail: [email protected]. About Dicot Pharma AB. Dicot Pharma is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile โ€ฆSee details»

Potensläkemedelsexpert: โ€Ett potentiellt paradigmskifteโ€

3 days ago Potensläkemedelsmarknaden kan sägas föddes 1998 med lanseringen av ett litet blått piller. Dr Padma-Nathan, ansvarig studieläkare i dess klinikarbete, var en av fältets โ€ฆSee details»

Dicot - Overview, News & Similar companies | ZoomInfo.com

Jan 5, 2024 View Dicot (www.dicot.se) location in Uppsala, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โ€ฆSee details»

Dicot Pharma - Mangold Fondkommission AB

Dicot Pharma Spotlight Stock Market. 0.19-1.27%. Stock information. Company Dicot Pharma; Currency SEK; Turnover 1 496 272 SEK %-1.27 + / --Buy 0.187; Sell 0.182; High 0.424; Low โ€ฆSee details»

Dicot Pharma (OM:DICOT) - Stock Price, News & Analysis - Simply โ€ฆ

Dec 4, 2024 Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature โ€ฆSee details»

MFN.se > Dicot > Dicot AB (publ): The pharmaceutical company โ€ฆ

The pharmaceutical company Dicot develops drugs within sexual dysfunctions with focus on bringing the drug candidate LIB-01 into clinical phase. Dicot will now strengthen and broaden โ€ฆSee details»

linkstock.net © 2022. All rights reserved